Trials / Completed
CompletedNCT02992561
Addressing Heightened Levels of Aggression in Traumatized Offenders With Psychotherapeutic Means
Addressing Heightened Levels of Aggression in Traumatized Offenders With Psychotherapeutic Means: A Randomized Controlled Trial in Eastern DR Congo
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 402 (actual)
- Sponsor
- University of Konstanz · Academic / Other
- Sex
- All
- Age
- 16 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Heightened levels of aggression are fuelling violent incidents at all levels, especially in post-war regions. Narrative Exposure Therapy for Forensic Offender Rehabilitation (FORNET) aims to address trauma symptoms along with reactive and instrumental/appetitive aggression to encounter the downward cycle of perpetration and enforce a sustainable (re-)integration into civil life. In the present study, the investigators provide an adapted version of FORNET to former combatants in the North Kivu, Eastern DR Congo. Structured baseline, 3 and 6 month follow up interviews will be administered to assess the main outcome measures recent violent acts and appetitive aggression.
Detailed description
Participants will be recruited through local NGOs and eligible clients randomized to the treatment or waitlist control group, respectively. The treatment will be provided by supervised local counsellors after a 4-week training. At baseline, 3-month and 6-month follow up, sociodemographic data, trauma exposure, perpetrated violent acts, PTSD, recent aggression, functionality and drug dependency will be assessed. The interviews will be conducted by blind Congolese psychological interviewers after an intensive 3-weeks training and continuous supervision.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | FORNET (adapted version) |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2019-03-01
- Completion
- 2019-03-01
- First posted
- 2016-12-14
- Last updated
- 2020-08-04
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02992561. Inclusion in this directory is not an endorsement.